Lung cancer is the leading cause of cancer death worldwide, and tobacco smoking is a recognized major risk factor for lung tumor development. We analyzed the effect of tobacco-specific nitrosamines (TSNAs) on human lung adenocarcinoma metabolic reprogramming, an emergent hallmark of carcinogenesis.
Results:
A series of in vitro and in vivo bioenergetic, proteomic, metabolomic, and tumor biology studies were performed to analyze changes in lung cancer cell metabolism and the consequences for hallmarks of cancer, including tumor growth, cancer cell invasion, and redox signaling. The findings revealed that nicotine-derived nitrosamine ketone (NNK) stimulates mitochondrial function and promotes lung tumor growth in vivo. These malignant properties were acquired from the induction of mitochondrial biogenesis induced by the upregulation and activation of the beta-2 adrenergic receptors (β2-AR)-cholinergic receptor nicotinic alpha 7 subunit (CHRNAα7)-dependent nitrosamine canonical signaling pathway. The observed NNK metabolic effects were mediated by TFAM overexpression and revealed a key role for mitochondrial reactive oxygen species and Annexin A1 in tumor growth promotion. Conversely, ectopic expression of the mitochondrial antioxidant enzyme manganese superoxide dismutase rescued the reprogramming and malignant metabolic effects of exposure to NNK and overexpression of TFAM, underlining the link between NNK and mitochondrial redox signaling in lung cancer.
Innovation:
Our findings describe the metabolic changes caused by NNK in a mechanistic framework for understanding how cigarette smoking causes lung cancer.
Conclusion:
Mitochondria play a role in the promotion of lung cancer induced by tobacco-specific nitrosamines. Antioxid. Redox Signal. 36, 525–549.
Get full access to this article
View all access options for this article.
References
1.
AmoedoND, DardL, SarlakS, MahfoufW, BlanchardW, RousseauB, IzotteJ, ClaverolS, LacombeD, RezvaniHR, PierriCL, and RossignolR. Targeting human lung adenocarcinoma with a suppressor of mitochondrial superoxide production. Antioxid Redox Signal, 33: 883–902, 2020.
2.
AmoedoND, ObreE, and RossignolR. Drug discovery strategies in the field of tumor energy metabolism: limitations by metabolic flexibility and metabolic resistance to chemotherapy. Biochim Biophys Acta Bioenerg, 1858: 674–685, 2017.
BenardG, FaustinB, PasserieuxE, GalinierA, RocherC, BellanceN, DelageJP, CasteillaL, LetellierT, and RossignolR. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol, 291: C1172–C1182, 2006.
5.
This reference has been deleted.
6.
BenardG, TrianT, BellanceN, BergerP, LavieJ, Espil-TarisC, RocherC, Eimer-BouillotS, GoizetC, Nouette-GaulainK, LetellierT, LacombeD, and RossignolR. Adaptative capacity of mitochondrial biogenesis and of mitochondrial dynamics in response to pathogenic respiratory chain dysfunction. Antioxid Redox Signal, 19: 350–365, 2013.
7.
BerndtsonWE.A simple, rapid and reliable method for selecting or assessing the number of replicates for animal experiments. J Anim Sci, 69: 67–76, 1991.
8.
BornemiszaP and SuciuI. Effect of cigarette smoking on the blood glucose level in normals and diabetics. Med Intern, 18: 353–356, 1980.
9.
BrandMD.Riding the tiger - physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix. Crit Rev Biochem Mol Biol, 55: 592–661, 2020.
10.
ChengG, ZielonkaJ, McAllisterD, HardyM, OuariO, JosephJ, DwinellMB, and KalyanaramanB. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: role of mitochondrial bioenergetics and energy-sensing mechanism. Cancer Lett, 365: 96–106, 2015.
11.
ChengG, ZielonkaJ, McAllisterDM, MackinnonAC, JosephJ, DwinellMB, and KalyanaramanB. Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death. BMC Cancer, 13: 285, 2013.
12.
ChuangC and HuM. Synergistic DNA damage and lipid peroxidation in cultured human white blood cells exposed to 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone and ultraviolet A. Environ Mol Mutagen, 47: 73–81, 2006.
13.
Cruz-BermúdezA, Laza-BriviescaR, Vicente-BlancoRJ, García-GrandeA, CoronadoMJ, Laine-MenéndezS, Palacios-ZambranoS, Moreno-VillaMR, Ruiz-ValdepeñasAM, LendinezC, RomeroA, FrancoF, CalvoV, AlfaroC, AcostaPM, SalasC, GarciaJM, and ProvencioM. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition. Free Radic Biol Med, 135: 167–181, 2019.
14.
DattaK, PatilS, PatelK, BabuN, RajaR, NanjappaV, MangalaparthiK, DhakaB, RajagopalanP, DeolankarS, KannanR, KumarP, PrasadT, MathurP, KumariA, ManoharanM, CoralK, MuruganS, SidranskyD, GuptaR, GuptaR, Khanna-GuptA, ChatterjeeA, and GowdaH. Chronic exposure to chewing tobacco induces metabolic reprogramming and cancer stem cell-like properties in esophageal epithelial cells. Cells, 8: 949, 2019.
15.
DemizuY, SasakiR, TrachoothamD, PelicanoH, ColacinoJ, LiuJ, and HuangP. Alterations of cellular redox state during NNK-induced malignant transformation and resistance to radiation. Antioxid Redox Signal, 10: 951–961, 2008.
16.
Dias AmoedoN, DardL, SarlakS, MahfoufW, BlanchardW, RousseauB, IzotteJ, ClaverolS, LacombeD, RezvaniHR, PierriCL, and RossignolR. Targeting human lung adenocarcinoma with a suppressor of mitochondrial superoxide production. Antioxid Redox Signal, 33: 883–902, 2020.
17.
Dias AmoedoN, SarlakS, ObreE, EstevesP, BégueretH, KiefferY, RousseauB, DupisA, IzotteJ, BellanceN, DardL, Redonnet-VernhetI, PunziG, Figueiredo RodriguesM, DumonE, MafhoufW, Guyonnet-DupératV, GalesL, PalamaT, BellvertF, Dugot-senanN, ClaverolS, BasteJ-M, LacombeD, RezvaniHR, Mechta-grigoriouF, ThumerelM, and RossignolR. Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest, 131: e133081, 2021.
18.
ElisiaI, ChoB, HayM, LiM, HofsE, LamV, DyerR, LumJ, and KrystalG. The effect of diet and exercise on tobacco carcinogen-induced lung cancer. Carcinogenesis, 40: 448–460, 2019.
19.
EstevesP, DardL, BrillacA, HubertC, SarlakS, RousseauB, DumonE, IzotteJ, BonneuM, LacombeD, DupuyJ-W, AmoedoN, and RossignolR. Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene, 39: 617–636, 2019.
20.
FaubertB, SolmonsonA, and DeBerardinisRJ. Metabolic reprogramming and cancer progression. Science (80-) 368, 2020.
21.
FilogranaR, MennuniM, AlsinaD, and LarssonN. Mitochondrial DNA copy number in human disease: the more the better?. FEBS Lett, 595: 976–1002, 2020.
22.
FokiE, GanglK, KranebitterV, Niederberger-LeppinV, Eckl-DornaJ, WiebringhausR, ThurnherD, and HeiduschkaG. Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma. Head Neck, 42: 2348–2354, 2020.
23.
GasparreG, KurelacI, CapristoM, IommariniL, GhelliA, CeccarelliC, NicolettiG, NanniP, De GiovanniC, ScotlandiK, BettsCM, CarelliV, LolliniPL, RomeoG, RugoloM, and PorcelliAM. A Mutation Threshold Distinguishes the Antitumorigenic Effects of the Mitochondrial Gene MTND1, an Oncojanus Function. Cancer Res, 71: 6220–6229, 2011.
24.
GentricG, KiefferY, MieuletV, GoundiamO, BonneauC, NematiF, HurbainI, RaposoG, PopovaT, SternM-H, Lallemand-BreitenbachV, MüllerS, CañequeT, RodriguezR, Vincent-SalomonA, de ThéH, RossignolR, and Mechta-GrigoriouF. PML-regulated mitochondrial metabolism enhances chemosensitivity in human ovarian cancers. Cell Metab, 29: 156–173.e10, 2019.
25.
GiordanoL, FarnhamA, DhandapaniP, SalminenL, BhaskaranJ, VoswinckelR, RauschkolbP, ScheibeS, SommerN, BeisswengerC, WeissmannN, BraunT, JacobsH, BalsR, HerrC, and SziborM. Alternative oxidase attenuates cigarette smoke-induced lung dysfunction and tissue damage. Am J Respir Cell Mol Biol, 60: 515–522, 2019.
26.
GrossmanRL, HeathAP, FerrettiV, VarmusHE, LowyDR, KibbeWA, and StaudtLM. Toward a shared vision for cancer genomic data. N Engl J Med, 375: 1109–1112, 2016.
27.
GuerraF, KurelacI, CormioA, ZuntiniR, AmatoLB, CeccarelliC, SantiniD, CormioG, FracassoF, SelvaggiL, RestaL, AttimonelliM, GadaletaMN, and GasparreG. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Hum Mol Genet, 20: 2394–2405, 2011.
28.
GushgariAJ and HaldenRU. Critical review of major sources of human exposure to N-nitrosamines. Chemosphere, 210: 1124–1136, 2018.
29.
HanahanD and WeinbergRA. Hallmarks of cancer: the next generation. Cell, 144: 646–674, 2011.
30.
HaqR, ShoagJ, Andreu-PerezP, YokoyamaS, EdelmanH, RoweGC, FrederickDT, HurleyAD, NelloreA, KungAL, WargoJA, SongJS, FisherDE, AranyZ, and WidlundHR. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell, 23: 302–315, 2013.
31.
HechtSS.Lung carcinogenesis by tobacco smoke. Int J cancer, 131: 2724–2732, 2012.
32.
HechtSS, MorseMA, AminS, StonerGD, JordanKG, ChoiCI, and ChungFL. Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. Carcinogenesis, 10: 1901–1904, 1989.
HosseiniM, DoussetL, MichonP, MahfoufW, MuzotteE, BergeronV, BortolottoD, RossignolR, MoisanF, TaiebA, Bouzier-SoreA-K, and RezvaniHR. UVB-induced DHODH upregulation, which is driven by STAT3, is a promising target for chemoprevention and combination therapy of photocarcinogenesis. Oncogenesis, 8: 52, 2019.
37.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Smokeless tobacco and some tobacco-specific N-nitrosamines. IARC Monogr Eval Carcinog Risks Hum, 89: 1–592, 2007.
38.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr Eval Carcinog Risks Hum, 92: 1–853, 2010.
39.
IdelchikMDPS, BegleyU, BegleyTJ, and MelendezJA. Mitochondrial ROS control of cancer. Semin Cancer Biol, 47: 57–66, 2017.
40.
KällL, CanterburyJD, WestonJ, NobleWS, and MacCossMJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods, 4: 923–925, 2007.
41.
LavieJ, SerratR, BellanceN, CourtandG, DupuyJ-W, TessonC, CoupryI, BriceA, LacombeD, DurrA, StevaninG, DariosF, RossignolR, GoizetC, and BènardG. Mitochondrial morphology and cellular distribution are altered in SPG31 patients and are linked to DRP1 hyperphosphorylation. Hum Mol Genet, 26: 674–685, 2017.
42.
LinR-K, HsiehY-S, LinP, HsuH-S, ChenC-Y, TangY-A, LeeC-F, and WangY-C. The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients. J Clin Invest, 120: 521, 2010.
43.
MasayesvaBG, MamboE, TaylorRJ, GoloubevaOG, ZhouS, CohenY, MinhasK, KochW, SciubbaJ, AlbergAJ, SidranskyD, and CalifanoJ. Mitochondrial DNA content increase in response to cigarette smoking. Cancer Epidemiol Biomarkers Prev, 15: 19–24, 2006.
NazarewiczRR, DikalovaA, BikineyevaA, IvanovS, KirilyukIA, Grigor'evIA, and DikalovSI. Does scavenging of mitochondrial superoxide attenuate cancer prosurvival signaling pathways?. Antioxid Redox Signal, 19: 344–349, 2013.
47.
OberleyLW and BuettnerGR. Role of superoxide dismutase in cancer: a review. Cancer Res, 39: 1141–1149, 1979.
48.
PavlovaNN and ThompsonCB. The emerging hallmarks of cancer metabolism. Cell Metab, 23: 27–47, 2016.
49.
PayenVL, PorporatoPE, DanhierP, VazeilleT, BlackmanMCNM, MayBH, NiebesP, and SonveauxP. (+)-Catechin in a 1:2 complex with lysine inhibits cancer cell migration and metastatic take in mice. Front Pharmacol, 8: 869, 2017.
50.
Pearson-StuttardJ, BennettJ, ChengYJ, VamosEP, CrossAJ, EzzatiM, and GreggEW. Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records. Lancet Diabetes Endocrinol, 9: 165–173, 2021.
51.
PorporatoPE, PayenVL, Pérez-EscuredoJ, De SaedeleerCJ, DanhierP, CopettiT, DhupS, TardyM, VazeilleT, BouzinC, FeronO, MichielsC, GallezB, and SonveauxP. A mitochondrial switch promotes tumor metastasis. Cell Rep, 8: 754–766, 2014.
52.
PresteR, VitaleO, ClimaR, GasparreG, and AttimonelliM. HmtVar: a new resource for human mitochondrial variations and pathogenicity data. Nucleic Acids Res, 47: D1202–D1210, 2019.
ReichmannH, VoglerL, and SeibelP. Ragged red or ragged blue fibers. Eur Neurol, 36: 98–102, 1996.
55.
RenD, ZhaoJ, SunY, LiD, MengZ, WangB, FanP, LiuZ, JinX, and WuH. Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway. J Exp Clin Cancer Res, 38: 485, 2019.
56.
RezvaniHR, KimAL, RossignolR, AliN, DalyM, MahfoufW, BellanceN, TaiebA, de VerneuilH, MazurierF, and BickersDR. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest, 121: 195–211, 2011.
57.
RezvaniHR, KimAL, RossignolR, AliN, DalyM, MahfoufW, BellanceN, TaïebA, De VerneuilH, MazurierF, and BickersDR. XPC silencing in normal human keratinocytes triggers metabolic alterations that drive the formation of squamous cell carcinomas. J Clin Invest, 121: 195–211, 2011.
58.
RheeHJ, KimGY, HuhJW, KimSW, and NaDS. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur J Biochem, 267: 3220–3225, 2000.
59.
RossignolR, MalgatM, MazatJP, and LetellierT. Threshold effect and tissue specificity. Implication for mitochondrial cytopathies. J Biol Chem, 274: 33426–33432, 1999.
60.
RubinsteinM, BaikJ, LaganaS, HanR, RaabW, SahooD, DalerbaP, WangT, and HanY. Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. EMBO Rep, 20: e47638, 2019.
61.
SarlakS, LalouC, AmoedoND, and RossignolR. Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer. Semin Cell Dev Biol, 98: 154–166, 2020.
62.
SchullerHM and CekanovaM. NNK-induced hamster lung adenocarcinomas over-express beta2-adrenergic and EGFR signaling pathways. Lung Cancer, 49: 35–45, 2005.
63.
SiegelDA, FedewaSA, HenleySJ, PollackLA, and JemalA. Proportion of never smokers among men and women with lung cancer in 7 US States. JAMA Oncol, 7: 302–304, 2021.
UphamTC, RaoM, AtaySM, SiddiquiMM, HongYK, RaijiMT, HongJA, ZhangMR, LinehanWM, and SchrumpDS. Cigarette smoke modulates glucose utilization in human lung cancer cells. J Am Coll Surg, 217: S40–S41, 2013.
66.
VazquezF, LimJ-H, ChimH, BhallaK, GirnunG, PierceK, ClishCB, GranterSR, WidlundHR, SpiegelmanBM, and PuigserverP. PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell, 23: 287–301, 2013.
67.
VermeulenR, SchymanskiEL, BarabásiA-L, and MillerGW. The exposome and health: where chemistry meets biology. Science (80-), 367: 392–396, 2020.
WalczakJ, MalińskaD, DrabikK, MichalskaB, PrillM, JohneS, LuettichK, SzymańskiJ, PeitschM, HoengJ, DuszyńskiJ, WięckowskiM, van der ToornM, and SzczepanowskaJ. Mitochondrial network and biogenesis in response to short and long-term exposure of human BEAS-2B cells to aerosol extracts from the tobacco heating system 2.2. Cell Physiol Biochem 54, 23, 0–251, 2020.
70.
WeinbergF, HamanakaR, WheatonWW, WeinbergS, JosephJ, LopezM, KalyanaramanB, MutluGM, BudingerGR, and ChandelNS. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci U S A, 107: 8788–8793, 2010.
71.
WestKA, BrognardJ, ClarkAS, LinnoilaIR, YangX, SwainSM, HarrisC, BelinskyS, and DennisPA. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest, 111: 81–90, 2003.
72.
WolfDA.Is Reliance on Mitochondrial Respiration a “Chink in the Armor” of Therapy-Resistant Cancer?. Cancer Cell, 26: 788–795, 2014.
73.
XieD, WuX, LanL, ShangguanF, LinX, ChenF, XuS, ZhangY, ChenZ, HuangK, WangR, WangL, SongX, LiuY, and LuB. Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics. Oncotarget, 7: 11609–11624, 2016.
74.
YiM and SchnitzerJE. Impaired tumor growth, metastasis, angiogenesis and wound healing in annexin A1-null mice. Proc Natl Acad Sci U S A, 106: 17886–17891, 2009.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
